Aliopharm

DIVISIONE ALIMENTARE
FUNCTIONAL FOODS AND NUTRACEUTICALS DIVISION

ALIOPHEN FOOD POWDER

Aliopharm
*Products and images are for illustrative purposes only. Specifications are subject to change without notice.
Aliopharm

ALIOPHEN® is a product obtained thanks to the Italian patent n° 102017000096298 entitled “Method for the production of a polyphenolic composition starting from barley malt” extended in Europe, USA, China and Canada jointly owned by ALIOPHARM ® and the National Research Council


Application

Aliopharm

AGRI-FOOD SECTOR

  • Food: can be used as an ingredient in other food products
  • Food Supplement: used in pure form or as a component of supplements
  • Functional Food: compliant with art. 2 of Reg. (EC) 178/2002, can be marketed as a supplement or functional ingredient

Products Available
ALIOPHEN FOOD POWDER
 
 
Alessandro Colletti

Alessandro Colletti

Technical, Scientific Consultant

MeSVA Department of the University of L'Aquila

A scientific collaboration coordinated by Prof. Davide Grassi is active between the MeSVA Department of the University of L'Aquila and Aliopharm.
Davide Grassi
Prof.

Davide Grassi


Institute of Food Sciences of the National Research Council of Avellino (CNR-ISA) and Aliopharm S.r.l.

A scientific collaboration agreement is in place between CNR-ISA and the company ALIOPHARM, coordinated by Dr. Gian Luigi Russo and Dr. Carmela Spagnuolo

Gian Luigi Russo
Dott.

Gian Luigi Russo

Carmela Spagnuolo
Dott.ssa

Carmela Spagnuolo

Aliopharm

Scientific Publications

The beneficial properties of the product resulting from the studies conducted have not been endorsed by the European Food Safety Authority (EFSA).
The beneficial effects of Aliophen ® on health have not been expressly recognized and authorized by EFSA.

Antioxidant and Chemopreventive Effect of Aliophen® Formulation Based on Malts and Hops

by Idolo Tedesco1,†, Carmela Spagnuolo1,†, Stefania Bilotto1, Angelo A. Izzo2, Francesca Borrelli2, Daniela Rigano2, Maria Russo1, Fabrizio Tarricone3 and Gian Luigi Russo1.

  1. 1 National Research Council, Institute of Food Sciences, 83100 Avellino, Italy
  2. 2 Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy
  3. 3 ALIOPHARM S.r.l., 20124 Milan, Italy
  4. * Author to whom correspondence should be addressed
  5. These authors equally contributed to this work

Antioxidants 2021, 10(1), 29;

Contacts

ALIOPHARM S.r.l.
with a single partner
Via Napo Torriani, 31
20124 Milano (MI) - Italy
VAT: 10359920963
Phone: (+39) 02.70017411
Email: info@aliopharm.com